Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

iSpecimen (ISPC) Revenue (2020 - 2025)

iSpecimen has reported Revenue over the past 6 years, most recently at $51761.0 for Q4 2025.

  • For Q4 2025, Revenue fell 96.49% year-over-year to $51761.0; the TTM value through Dec 2025 reached $1.9 million, down 79.24%, while the annual FY2025 figure was $1.9 million, 79.24% down from the prior year.
  • Revenue for Q4 2025 was $51761.0 at iSpecimen, down from $106592.0 in the prior quarter.
  • Over five years, Revenue peaked at $3.0 million in Q1 2021 and troughed at $51761.0 in Q4 2025.
  • A 5-year average of $2.1 million and a median of $2.6 million in 2021 define the central range for Revenue.
  • Biggest five-year swings in Revenue: soared 93.0% in 2021 and later tumbled 96.49% in 2025.
  • Year by year, Revenue stood at $2.5 million in 2021, then rose by 16.18% to $3.0 million in 2022, then fell by 13.05% to $2.6 million in 2023, then plummeted by 42.7% to $1.5 million in 2024, then tumbled by 96.49% to $51761.0 in 2025.
  • Business Quant data shows Revenue for ISPC at $51761.0 in Q4 2025, $106592.0 in Q3 2025, and $713135.0 in Q2 2025.